Patient info Open main menu

SAPVIT-D3 14 400 IU/ML ORAL DROPS SOLUTION - patient leaflet, side effects, dosage

Dostupné balení:

Patient leaflet - SAPVIT-D3 14 400 IU/ML ORAL DROPS SOLUTION

Sapvit-D3


14,400 IU/ml oral drops, solution cholecalciferol (vitamin D3)


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • – Keep this leaflet. You may need to read it again.

  • – If you have any further questions, ask your doctor or pharmacist.

  • – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

  • – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

  • 1 What Sapvit-D3 is and what it is used for

  • 2 What you need to know before you take Sapvit-D3

  • 3 How to take Sapvit-D3

  • 4 Possible side effects

  • 5 How to store Sapvit-D3

  • 6 Contents of the pack and other information

  • j | What Sapvit-D 3

is and what it is used for

Sapvit-D3 contains the active substance cholecalciferol (vitamin D3).

Sapvit-D3 is used:

  • – for prevention and treatment of vitamin D deficiency.

  • – for treatment of rickets (a condition that affects bone development in children).

  • – as an adjunct to osteoporosis treatment of patients who are at risk of vitamin D deficiency.

J2|

What you need to know before you take Sapvit-D

3

Do not take Sapvit-D3:

  • – if you are allergic to cholecalciferol or any of the other ingredients of this medicine (listed in section 6).

  • – if you suffer from medical conditions that result in a high calcium level in the blood or increased calcium excretion in the urine (as with treatment with certain medicines [benzothiazine derivates] or if you are bedridden).

■ – if you suffer or have a tendency to suffer from calcium-containing kidney stones.

  • – if you suffer from an excess of vitamin D.

  • – if you have severe arteriosclerosis (hardening of the arteries).

  • – if you suffer from severe kidney dysfunction.

Warnings and precautions

Talk to your doctor or pharmacist before taking Sapvit-D3.

Special care when taking Sapvit-D3 is required,

  • – if you are being treated with certain heart drugs (cardiac glycosides) or thiazide-type diuretic drugs.

  • – if you suffer from kidney dysfunction. Your doctor will monitor the calcium and phosphate levels in the blood in this case. The risk of soft tissue calcification has to be considered.

  • – in severe kidney dysfunction, cholecalciferol is not utilized. Your doctor will possibly recommend another vitamin D supplement.

  • – if you suffer from sarcoidosis (Boeck’s disease), there is a risk of increased formation of the active form of vitamin D.

  • – in case of reduced bone mass due to inactivity (e.g. bedrest) there is an increased risk of occurrence of elevated calcium levels in the blood.

During long-term use, your doctor will check the levels of calcium in your blood and urine regularly and monitor your kidney function. If necessary, your doctor may tell you to reduce the dose or stop the treatment.

Raised parathyroid hormone levels can enhance the vitamin D metabolism and this increases the vitamin D requirement.

Additional doses of vitamin D should only be taken under close medical supervision.

Children and adolescents

Avoid the use of other vitamin D-containing products, especially in infants. If in doubt, your doctor will decide about the additional use of vitamin-enriched foods or baby foods and vitamin D-containing medicines.

Other medicines and Sapvit-D3

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is especially important if you are taking:

  • Rifampicin or isoniazid (against tuberculosis).
  • Certain heart medicines (cardiac glycosides): they may enhance their harmful effects by increasing the blood calcium levels (risk of arrhythmias). A strict medical supervision is required, possibly including electrocardiogram (ECG) examination and control of the calcium level in the blood.
  • Thiazide diuretics: they increase the risk for the occurrence of elevated calcium levels in the blood, because these drugs reduce the urinary excretion of calcium. Your doctor will check your blood calcium levels regularly in this case.
  • „ – “Me“dicines“for“the treatment "of epilepsy (carbamazeprne,“phe­nobarbitai,“phe­nytoin,“ primidone) or“ “ “ certain hormones of the adrenal cortex (glucocorticoids, ‘cortisone’): they may increase your vitamin D requirement.
  • Medicines to lower blood lipids (e.g. orlistat and cholestyramine): they may reduce the absorption of vitamin D through the intestines.
  • Medicines containing magnesium (e.g. antacids): they should not be used during Sapvit-D3-therapy as this may lead to high levels of magnesium in the blood (hypermagnesaemia).
  • Aluminium-containing pills (against heartburn).

Sapvit-D3 with food and drink

Caution is advised concerning vitamin-enriched food or infant formula.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

If your doctor prescribes Sapvit-D3 when you are pregnant, be careful to keep strictly to the dose your doctor has prescribed, since overdose of vitamin D3 may involve a risk of physical and mental retardation, as well as heart and eye diseases of your child.

Breast-feeding

Vitamin D and its metabolites pass into breast milk. Overdose in infants induced by nursing has not been observed. This fact, however, should be taken into account if the child receives additional vitamin D.

Driving and using machines

Sapvit-D3 has no or negligible influence on the ability to drive and use machines.

|3|

How to take Sapvit-D

3

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The dosage will be determined by your doctor. The dose depends on the condition for which you get Sapvit-D3. Therefore, always take the dose that has been prescribed individually for you, even if you know someone else who has been prescribed a much higher dose.

Unless otherwise prescribed by your doctor, the recommended dose is:

lackground brg ।


Prevention of vitamin D deficiency:

The usual daily dose is:

  • For newborns, infants and children from the second week of life to the age of 3 years: between 1–2 drops
  • For children aged 4 years and above and adolescents: between 1–3 drops
  • For adults aged 19 to 70 years: between 1–4 drops
  • For elderly people aged above 70 years: between 2–4 drops

Treatment of rickets

The total amount of required vitamin D depends on the severity of the disease.

In existing rickets, treatment is started with a preparation with a higher concentration of vitamin D for the initial treatment.

Subsequently, the usual dose is between 2 to 12 drops of Sapvit-D3 daily.

Treatment of vitamin D deficiency

The usual daily dose is:

  • For children and adolescents: 5 drops daily for 6 weeks, then between 1–3 drops daily
  • For adults aged 19 to 70 years and elderly people aged above 70 years: 15 drops daily for 8 weeks, then between 3–5 drops daily

Adjunct to osteoporosis treatment of patients who are at risk of vitamin D deficiency

The usual daily dose is:

  • For adults aged 19 years and above: between 2–4 drops daily or between 14–26 drops weekly

Method of administration

Sapvit-D3 drops are taken directly orally. The best way is to drip them straight into the mouth or, if necessary, administer with a spoon and some liquid.

Please talk to your doctor or pharmacist if you have the impression that the effect of Sapvit-D3 is too strong or too weak.

Instruction for handling


For withdrawal, hold the bottle vertically and gently tap the bottom of the bottle with your finger until the first drop appears.


If you take more Sapvit-D3 than you should

In case of overdose with Sapvit-D3 drops you should contact a doctor.

Symptoms of overdose may include: headache, loss of appetite, weakness, weight loss, disorders of the gastrointestinal tract (feeling sick, vomiting, constipation), growth disorders, increased urine volume, increased fluid intake, signs of paralysis, feebleness, increased blood pressure and in severe cases irregular heart beat.

The doctor decides on the severity of poisoning and determines the required treatment.

If you forget to take Sapvit-D3

Do not take a double dose to make up for a forgotten dose.

If you stop taking Sapvit-D3

No withdrawal symptoms are known.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

]4]

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Vitamin D can cause the following undesirable effects, especially in overdose:

Metabolism and nutrition disorders:

Too high calcium levels in blood and urine (hypercalcaemia, hypercalciuria).

Gastrointestinal disorders:

Constipation, bloating, feeling sick, stomach ache, diarrhoea.

Frequency of the occurrence of the above mentioned side effects is not known (cannot be estimated from the available data).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:. By reporting side effects you can help provide more information on the safety of this medicine.


]5]

How to store Sapvit-D

3
  • – Do not store above 30°C.

  • – Keep the bottle in the outer carton in order to protect from light.

  • – Keep this medicine out of the sight and reach of children.

  • – Do not use this medicine after the expiry date which is stated on the label and carton after EXP.

The expiry date refers to the last day of that month.

  • – After opening the container, use Sapvit-D3 oral drops within 10 months. Any unused product should be disposed of thereafter. Do not store above 25°C after first opening.

  • – Do not use this medicine if you notice the following: turbidity or discolouration of the solution.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

]6]

Contents of the pack and other information

What Sapvit-D3 contains

  • – The active substance is: cholecalciferol (vitamin D3).

What Sapvit-D3 looks like and contents of the pack

Sapvit-D3 are clear, colourless to slightly yellowish oral drops (oily solution) and are available in brown glass bottles containing 12.5 ml each (corresponding to 450 drops) with dropper applicator and screw cap with tamper evident ring made of polyethylene.

Marketing Authorisation Holder and Manufacturer

Fresenius Kabi Austria GmbH

HafnerstraBe 36

8055 Graz

Austria

tel: +43 316 249 0

fax: +43 316 249 1470

email:


Distributor:

Stirling Anglian Pharmaceuticals Ltd, Hillington Park Innovation Centre, 1 Ainslie Road, Hillington Park, Glasgow G52 4RU

United Kingdom


This medicinal product is authorised in the Member States of the EEA under the following names:

Austria: Colecalciferol Fresenius 14.400 I.E./ml Tropfen zum Einnehmen, Losung

Bulgaria: OreoBUT D3 14 400 lU/ml nepoparHu KanKu, pa3TBop

Czech Republic: Olvit D3 14400 lU/ml peroralm kapky, roztok

Germany: Oleo-De3 Tropfen zum Einnehmen 14.400 I.E./ml, Lo­sung

Hungary: Oleovit-D3 cseppek

Ireland: Sapvit-D3 400 IU/drop Oral Drops, Solution

Slovakia: Olvit D3, 14 400 lU/ml peroralne roztokove kvapky

Slovenia: Oleovit D3 14400 i.e./ml peroralne kapljice, raztopina

Sweden: Oleo D3 14 400 lE/ml orala droppar, losning

This leaflet was last revised in 01/2018

The following information is intended for healthcare professionals only:

Overdose

Overdose can lead to hypervitaminosis and hypercalcaemia. Hypervitaminosis is expressed in uncharacteristic symptoms such as headache, loss of appetite, weakness, weight loss, gastrointestinal disturbances (nausea, vomiting, constipation) and growth disorders.

Persisting hypercalcaemia may lead to polyuria, polydipsia, nausea, vomiting, constipation, muscle weakness, paresis, adynamia, nocturia, proteinuria, anorexia, hypercholeste­rolaemia, elevated transaminase levels, cardiac arryhthmias, hypertension and radiographically detectable soft tissue calcification.

The vitamin D effect is reversed in severe overdose. Bones are decalcified and calcium levels in blood and urine increase. Calcification can occur in tissue, blood vessels and kidneys. Furthermore, mental changes up to psychosis can occur.

Treatment

Treatment with vitamin D must be discontinued immediately and dehydration corrected in case of an intoxication. Other measures: diet low in calcium, calcitonin, glucocorticoids.


Date:

08–03–2018

Client:

StirlingAnglian Pharmaceuticals

Leaflet (PIL):

Sapvit-D3 14,400 lU/ml oral drops cholecalciferol (vitamin D3)

Version:

UK v12

Colour:

Black

Size:

155 mm x 600 mm

Font:

Helvetica Neue (Regular, Bold)

Font size:

8 pt, leading 9.6 pt

V0058792/01